These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 16052670)
1. Role of stress-activated MAP kinase P38 in cisplatin- and DTT-induced apoptosis of the esophageal carcinoma cell line Eca109. Zhang QX; Feng R; Zhang W; Ding Y; Yang JY; Liu GH World J Gastroenterol; 2005 Aug; 11(29):4451-6. PubMed ID: 16052670 [TBL] [Abstract][Full Text] [Related]
2. [Overexpression of Smac gene enhanced chemotherapeutic sensitivity of esophageal cancer cell line Eca109 to cisplatin]. Du N; Yang B; Hu LJ; Zhao Y; Sun X; Guo ZW; Ren H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):344-6. PubMed ID: 22482401 [TBL] [Abstract][Full Text] [Related]
3. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment]. Zhang YX; Kong CZ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842 [TBL] [Abstract][Full Text] [Related]
4. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344 [TBL] [Abstract][Full Text] [Related]
5. The regulatory effect of the p38 signaling pathway on valdecoxib-induced apoptosis of the Eca109 cell line. Liu SX; Zhang YJ; Guo HF; Hao J; Liu QJ; Liu JR; Guo JW; Liu JH; Zuo LF Oncol Rep; 2009 Aug; 22(2):313-9. PubMed ID: 19578771 [TBL] [Abstract][Full Text] [Related]
6. c-Myc potentiates the mitochondrial pathway of apoptosis by acting upstream of apoptosis signal-regulating kinase 1 (Ask1) in the p38 signalling cascade. Desbiens KM; Deschesnes RG; Labrie MM; Desfossés Y; Lambert H; Landry J; Bellmann K Biochem J; 2003 Jun; 372(Pt 2):631-41. PubMed ID: 12646044 [TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity. Zhang Y; Shen X Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38-MAPK potentiates cisplatin-induced apoptosis via GSH depletion and increases intracellular drug accumulation in growth-arrested kidney tubular epithelial cells. Rodríguez-García ME; Quiroga AG; Castro J; Ortiz A; Aller P; Mata F Toxicol Sci; 2009 Oct; 111(2):413-23. PubMed ID: 19578154 [TBL] [Abstract][Full Text] [Related]
9. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis. Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564 [TBL] [Abstract][Full Text] [Related]
10. Melatonin Induces Cell Apoptosis in AGS Cells Through the Activation of JNK and P38 MAPK and the Suppression of Nuclear Factor-Kappa B: a Novel Therapeutic Implication for Gastric Cancer. Li W; Fan M; Chen Y; Zhao Q; Song C; Yan Y; Jin Y; Huang Z; Lin C; Wu J Cell Physiol Biochem; 2015; 37(6):2323-38. PubMed ID: 26645893 [TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Ohtsuka T; Buchsbaum D; Oliver P; Makhija S; Kimberly R; Zhou T Oncogene; 2003 Apr; 22(13):2034-44. PubMed ID: 12673208 [TBL] [Abstract][Full Text] [Related]
12. Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase. Cadalbert L; Sloss CM; Cameron P; Plevin R Cell Signal; 2005 Oct; 17(10):1254-64. PubMed ID: 16038800 [TBL] [Abstract][Full Text] [Related]
13. 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells. Ahn YH; Jung JM; Hong SH Cancer Res; 2005 Jun; 65(11):4896-901. PubMed ID: 15930311 [TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells. Liu L; Ju Y; Wang J; Zhou R Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574 [TBL] [Abstract][Full Text] [Related]
15. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715 [TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma. Liu Z; Sun C; Zhang Y; Ji Z; Yang G J Int Med Res; 2011; 39(4):1319-32. PubMed ID: 21986133 [TBL] [Abstract][Full Text] [Related]
17. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418 [TBL] [Abstract][Full Text] [Related]
18. [Effect of mitogen-activated protein kinase signaling pathway on apoptosis induced by chloroacetic acid in human normal bronchial epithelial 16HBE cells]. Meng T; Yang M; Li YX; Jia Q; Yu GC; Dai YF Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 May; 35(5):321-327. PubMed ID: 28780785 [No Abstract] [Full Text] [Related]
19. Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485 [TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals. Ma D; Warabi E; Yanagawa T; Kimura S; Harada H; Yamagata K; Ishii T Oral Oncol; 2009 Dec; 45(12):1037-43. PubMed ID: 19692293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]